Login / Signup
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: No.
Emma Clare Tallantyre
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Keyphrases
</>